Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-25 4:30 pm Purchase |
2024-10-18 | 13G | TuHURA Biosciences, Inc. HURA |
Theofilos Charles Steve | 2,506,321 5.900% |
2,506,321 (New Position) |
Filing History |
| 2024-10-25 4:28 pm Purchase |
2024-10-18 | 13G | TuHURA Biosciences, Inc. HURA |
Patel Samir Rashmikant | 2,466,377 5.800% |
2,466,377 (New Position) |
Filing History |
| 2024-10-25 4:26 pm Purchase |
2024-10-18 | 13G | TuHURA Biosciences, Inc. HURA |
KP Biotech Group LLC | 2,572,582 6.100% |
2,572,582 (New Position) |
Filing History |
| 2024-10-25 4:23 pm Purchase |
2024-10-18 | 13G | TuHURA Biosciences, Inc. HURA |
CA Patel F&F Investments LLC | 2,572,582 6.100% |
2,572,582 (New Position) |
Filing History |
| 2024-10-25 4:20 pm Purchase |
2024-10-18 | 13D | TuHURA Biosciences, Inc. HURA |
Patel Vijay | 12,346,430 26.700% |
12,346,430 (New Position) |
Filing History |
| 2024-10-25 4:16 pm Purchase |
2024-10-18 | 13D | TuHURA Biosciences, Inc. HURA |
BIANCO JAMES A | 2,704,901 6.400% |
2,704,901 (New Position) |
Filing History |
| 2023-02-13 4:29 pm Purchase |
2022-12-31 | 13G | Kintara Therapeutics, Inc. KTRA |
Lind Global Fund II LP | 2,156 0.100% |
2,156 (New Position) |
Filing History |
| 2022-04-20 5:11 pm Purchase |
2022-04-14 | 13G | Kintara Therapeutics, Inc. KTRA |
Lind Global Fund II LP | 2,156 5.800% |
2,156 (New Position) |
Filing History |
| 2022-02-07 1:26 pm Sale |
2021-12-31 | 13G | Kintara Therapeutics, Inc. KTRA |
Pilkiewicz Carolyn | 669 2.410% |
-321 (-32.46%) |
Filing History |
| 2021-02-08 3:18 pm Sale |
2020-12-31 | 13G | Kintara Therapeutics, Inc. KTRA |
Pilkiewicz Carolyn | 990 7.030% |
-300 (-23.25%) |
Filing History |
| 2021-01-29 07:00 am Purchase |
2020-12-31 | 13G | Kintara Therapeutics, Inc. KTRA |
Mitchell P. Kopin | 514 3.500% |
514 (New Position) |
Filing History |
| 2020-11-16 2:37 pm Purchase |
2020-08-19 | 13G | Kintara Therapeutics, Inc. KTRA |
Pilkiewicz Carolyn | 1,290 9.150% |
1,290 (New Position) |
Filing History |
| 2020-08-28 4:05 pm Purchase |
2020-08-19 | 13G | Kintara Therapeutics, Inc. KTRA |
STERN ADAM K | 945 6.950% |
945 (New Position) |
Filing History |